Back to Search
REETIKA KUMAR, M.D.
M.D.
Internal Medicine Physician
NPI: 1548362742Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Neoplastic transformation by the gep oncogene, Galpha12, involves signaling by STAT3.
PMID 16247467·Oncogene·2006
7-preclinical
18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
PMID 16882175·Br J Dermatol·2006
8-other
Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12.
PMID 16354679·Mol Cell Biol·2006
7-preclinical
FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer.
PMID 16479242·Nucl Med Commun·2006
3-trial
Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.
PMID 16269595·J Nucl Med·2005
3-trial
Fluorodeoxyglucose-PET in the management of malignant melanoma.
PMID 15693645·Radiol Clin North Am·2005
6-review
F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast.
PMID 15764881·Clin Nucl Med·2005
5-case
FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature.
PMID 15764875·Clin Nucl Med·2005
5-case
Fluorodeoxyglucose-PET in the management of breast cancer.
PMID 15488561·Radiol Clin North Am·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 833 CHESTNUT ST, SUITE 701
PHILADELPHIA, PA 19107 - Phone
- (215) 955-6180
Quick Facts
- NPI
- 1548362742
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile